EcoDrugPlus

Ensembl ID : ENSUAMG00000005712
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSUAMG00000005702
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSUAMG00000005596
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSUAMG00000005549
Gene Symbol: -
Cross references: -
678 Possible Orthologues:

Ensembl ID : ENSUAMG00000004302
Gene Symbol: -
Cross references: -
264 Possible Orthologues:

Ensembl ID : ENSUAMG00000014560
Gene Symbol: -
Cross references: -
56 Possible Orthologues:

Ensembl ID : ENSUAMG00000018069
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSUAMG00000004300
Gene Symbol: -
Cross references: -
264 Possible Orthologues:

Ensembl ID : ENSUAMG00000004214
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSUAMG00000004153
Gene Symbol: -
Cross references: -
175 Possible Orthologues:

Ensembl ID : ENSUAMG00000003917
Gene Symbol: -
Cross references: -
159 Possible Orthologues:

Ensembl ID : ENSUAMG00000003540
Gene Symbol: -
Cross references: -
79 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).